SPACs lose their spark with deals hard to find
Around Indiana and the nation in recent weeks, special purpose acquisition companies, or SPACs, are shutting down and returning money to investors. In other cases, investors are taking a bath.
John Russell
Articles
33 state laptops missing from COVID vaccination scheduling program
The Indiana Office of Technology, which purchases and distributes computers for state work, does not have an audit trail of the missing computers, an investigation found.
Indianapolis dermatologist pleads guilty to understating taxes
Dr. A. David Gerstein, a dermatologist with practice on North Meridian Street, filed a plea agreement Dec. 28 in U.S. District Court in Indianapolis.
2022 Newsmaker: Ricks sends Indiana officials a wakeup call as Lilly stock soars
Some business leaders said Ricks’ message was a wake-up call about the need to make big improvements in schooling, health care and social policies.
2022 Newsmaker: Elanco intends to make new HQ ‘epicenter of animal health innovation’
On paper, it’s a global headquarters project—a $100 million campus for Elanco Animal Health on the former General Motors stamping plant site just west of downtown. But CEO Jeff Simmons is hoping it will become much more.
Leader of Franciscan Health’s local hospitals promoted to corporate position
Dr. James Callaghan, CEO of Franciscan Health’s central Indiana hospitals since 2015, has been named senior vice president and chief operating officer for Mishawaka-based Franciscan Alliance.
Emmis ‘blank check’ firm dissolves without making purchase
The company had raised $251 million in its initial public offering in January 2021, and has been on the hunt since then for companies to buy. But with the market cooling, it was unable to close any deals.
With stock trading near record high, Lilly embarks on ambitious 2023
The Indianapolis-based pharmaceutical company is preparing for one of its most ambitious years in memory for 2023, with plans to advance five new drugs into late-stage clinical studies and move four into regulatory review.
Q&A: Foundation president focuses on Hoosier health
As president of Indiana University Health Foundation, Crystal Miller oversees $300 million in net assets and 50 employees.
Physician shortage in rural areas means big business for Indy firm
OPYS Physician Services LLC, a 10-year-old Indianapolis company, provides doctors to hospitals, mostly in rural areas, to staff their emergency rooms and other critical areas.
Diabetes drug Lilly abandoned has new life
In an amazing resurrection, teplizumab, developed by another company after Lilly trials were a letdown, is one of the hottest new drugs on the market.
Eli Lilly’s report card on racial justice effort shows $15.6M in donations
The Indianapolis-based drugmaker released a report card Thursday that outlined its progress “to support effective solutions” to racial inequity and social injustice. In addition to donations, the company has committed tens of millions of dollars to other diversity efforts.
Corteva buys Houston-based plant biologics company for $1.2B
The acquisition is designed to accelerate Indianapolis-based Corteva’s biologicals business and make it one of the largest players in the market.
Corteva cutting 1,000 workers globally, including at Indianapolis HQ
Corteva Inc., the Indianapolis-based seed and insecticide giant, is cutting 5% of its global workforce, or roughly 1,000 workers, as it reduces its portfolio of products and streamlines its operations.
Unorthodox primary care provider ChenMed entering Indy market
The fast-growing, family-owned operation, based in Miami, has filed plans with the state to renovate three buildings and open them as primary care medical clinics.
55 Indiana hospitals facing fines for excessive readmissions
The number is down from 62 hospitals last year and 66 the before, but will still cost many hospitals money while they are still dealing with the strain of the pandemic that has overwhelmed resources and reduced their revenue and profits.
Staffing shortages rock pharmacy industry
While they scramble to fill positions, some pharmacies are cutting their hours or closing locations. That means patients are waiting longer to get their prescriptions filled.
Point Biopharma finds big licensing partner, but stock falls after Q3 loss widens
It was supposed to be a “good-news” day for Indianapolis-based biotech Point Biopharma Global Inc. Instead, the company saw its stock get battered Monday, losing as much as 38% of its value, after it released a pair of announcements.
MBX Biosciences closes on $115M in drug-development funding
The funding amount is one of the largest in recent years for an Indiana-based science startup.
Youth summit seeks to increase Black enrollment in medical schools
Hospitals and clinics are full of doctors in white coats. But only a tiny portion of them, about 4%, are Black.